DEMO SA: “We Bring the Future into the Present” The company announced its 2021-2027 investment plan, worth EUR 356 million.
On Tuesday, November 9, 2021, the CEO of the pharmaceutical industry, Mr. Dimitris Demos, presented the company’s multidimensional investment package…
Positive messages from the use of Dexamethasone for coping with Covid-19. In 2021, DEMO SA shall launch a Dexamethasone formulation in Greece.
The DEMO Pharmaceutical Industry with 4 manufacturing units located in Kryoneri - Attica, shall be launching within the next few months, the…
Event for the New Year’s cake organized by DEMO ABEE Turnover increase by 16 million euros in comparison to 2018 New Investment Plan of the company for the following 5 years
With our wishes for a creative year, the Pharmaceutical industry DEMO ΑΒΕΕ welcomed 2020 in an event for the New Year’s Cake, which took place on…
DEMO SA wins Gold at the Manufacturing Excellence Awards 2019
DEMO SA Pharmaceutical Industry received the Gold Award for Manufacturing Excellence in the Pharmaceutical & Cosmetics Category at the Manufacturing…
Event of cutting the New Year’s cake organized by DEMO S.A. Pharmaceutical Industry The company’s new Investment Plan for 2019-2022 of a total amount of 30 million Euros
DEMO S.A. Pharmaceutical Industry welcomed 2019, expressing wishes for a creative new year at the event organized for cutting the New Year’s cake.…
DEMO S.A. Pharmaceutical Industry Two Golden Awards in the DEVELOPMENT section at the “Healthcare Business Awards 2018”
DEMO S.A. Pharmaceutical Industry stood out with two Golden Awards in the category for pharmaceutical companies during the “Healthcare Business…
Cutting the new year’ cake at DEMO S.A.
The pharmaceutical industry DEMO S.A. welcomed 2018 with wishes for a creative new year, at the event for the cutting of the New Year’s traditional…